Latest market price
22.72
+0.19+0.84%
TNGXQT63Tango Therapeutics, Inc.·NASDAQ
22.72+0.84%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 23, 20268-KCurrent report
Oct 05, 20264Statement of changes in beneficial ownership
Sep 24, 20264Statement of changes in beneficial ownership
Sep 03, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 14, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Aug 11, 2026424B5Prospectus
Aug 11, 20268-KCurrent report
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 07, 20268-K/ACurrent report (amended)
Aug 06, 20268-KCurrent report
Aug 05, 20264Statement of changes in beneficial ownership
Jul 02, 20264Statement of changes in beneficial ownership
Jun 23, 20268-KCurrent report
Jun 23, 20264Statement of changes in beneficial ownership
Jun 23, 20263Initial statement of beneficial ownership
Jun 10, 2026FWPFree writing prospectus
Jun 10, 2026424B5Prospectus
Jun 10, 20268-KCurrent report
Jun 08, 20264Statement of changes in beneficial ownership